Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The pivotal trial supporting its 2010 FDA approval enrolled 816 HIV-infected adults with clinically defined lipodystrophy, and Phase 3 data documented visceral fat reductions of roughly 15-18% over 26 weeks of treatment a result robust enough to clear FDA review for a defined medical indication
Specific Considerations Peptides Containing Cysteine, Methionine, or Tryptophan Peptides with these amino acids are prone to oxidation
Items marked "" are certified
If still cloudy after 30 minutes, contact your source
US$ 28.52
US$ 24.59
US$ 22.55
US$ 24.32
US$ 26.27
